Avai Bio (AVAI) Total Current Liabilities (2018 - 2025)

Avai Bio has disclosed Total Current Liabilities across 8 years of filings, most recently posting $3.0 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $3.0 million, up 28.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (up 28.43% YoY), and the FY2025 annual result was $1.8 million, changed 0.0% from the prior year.
• Total Current Liabilities came in at $3.0 million for Q4 2025 at Avai Bio, up from $2.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $3.0 million in Q4 2025 to a low of $758471.0 in Q3 2022.
• The 5-year median for Total Current Liabilities is $1.3 million (2023), against an average of $1.5 million.
• Peak annual rise in Total Current Liabilities reached 149.9% in 2021, while the deepest fall reached 33.22% in 2021.
• Avai Bio's Total Current Liabilities stood at $844031.0 in 2021, then fell by 2.33% to $824372.0 in 2022, then jumped by 105.26% to $1.7 million in 2023, then soared by 36.54% to $2.3 million in 2024, then climbed by 28.43% to $3.0 million in 2025.
• The last three Total Current Liabilities figures came in at $3.0 million (Q4 2025), $2.5 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.